Tacrolimus causes reduced GLI1 expression and phenotypic changes in the TE 354.T basal cell carcinoma cell line

Journal of Dermatological Science

Volumn 54, Issue 1, 2009, Pages 52-54

  Di Gennaro, P ^a   Sestini, R ^a   Bacci, S ^a   Pacini, A ^a   Pinzani, P ^a   Domenici, L ^a   Toscano, A ^a   Massi, D ^a   Carli, P ^a   Genuardi, M ^a   Romagnoli, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

BCL 2; Electron microscopy; GLI1; Immunocytochemistry; Laminin; TE 354.T

Indexed keywords

LAMININ; MESSENGER RNA; PROTEIN BCL 2; TACROLIMUS; TRANSCRIPTION FACTOR GLI1;

BASAL CELL CARCINOMA; BASEMENT MEMBRANE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LETTER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION; WESTERN BLOTTING;

BLOOD COAGULATION FACTORS; CARCINOMA, BASAL CELL; CELL LINE, TUMOR; GENE EXPRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; TACROLIMUS; TRANSCRIPTION FACTORS;

EID: 60749120551     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.10.006     Document Type: Letter

References (10)

1. Villavicencio E.H., Walterhouse D.O., and Iannaccone P.M. The sonic hedgehog-patched-gli pathway in human development and disease. Am J Hum Genet 67 (2000) 1047-1054
2. Ghali L., Wong S.T., Green J., Tidman N., and Quinn A.G. Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin. J Invest Dermatol 113 (1999) 595-599
3. Green J., Leigh I.M., Poulsom R., and Quinn A.G. Basal cell carcinoma development is associated with induction of the expression of the transcription factor Gli-1. Br J Dermatol 139 (1998) 911-915
4. Hatta N., Hirano T., Kimura T., Hashimoto K., Mehregan D.R., Ansai S., et al. Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels. J Cutan Pathol 32 (2005) 131-136
5. Goto T., Kino T., Hatanaka H., Nishiyama M., Okuhara M., Kohsaka M., et al. Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc 19 (1987) 4-8
6. Kim A., DiCarlo J., Cohen C., McCall C., Johnson D., McAlpine B., et al. Are keloids really "gli-loids"?: High-level expression of gli-1 oncogene in keloids. J Am Acad Dermatol 45 (2001) 707-711
7. Macaron N.C., Cohen C., Chen S.C., and Arbiser J.L. GLI-1 oncogene is highly expressed in granulomatous skin disorders, including sarcoidosis, granuloma annulare, and necrobiosis lipoidica diabeticorum. Arch Dermatol 141 (2005) 259-262
8. Zhan M., Zhao H., and Han Z.C. Signalling mechanisms of anoikis. Histol Histopathol 19 (2004) 973-983
9. Evans A.V. The expanding role of topical tacrolimus in dermatology. Clin Exp Dermatol 30 (2005) 111-115
10. Niwa Y., Terashima T., and Sumi H. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br J Dermatol 149 (2003) 960-967